Leading company signs execution drug 'Hippocratic Oath'

By agency reporter
March 28, 2012

The leading pharmaceutical company Lundbeck has become the first to sign up to a new ‘Pharmaceutical Hippocratic oath’ for the industry which condemns the use of drugs in executions. (http://www.ekklesia.co.uk/node/16462)

The pledge builds on last year’s successful move by the firm to prevent its products being used to carry out the death penalty in the US, while ensuring that they remain available for legitimate medical use.

The legal action charity Reprieve is now urging other pharmaceutical companies to follow Lundbeck’s lead in signing up to the Pharmaceutical Hippocratic Oath, and ensuring that their drugs do not reach US execution chambers.

Reprieve investigator, Maya Foa said: "Pharmaceutical companies are growing increasingly vocal in their opposition to the abuse of their medicines in US executions. This is a powerful statement from Lundbeck, affirming that the right to health of the patient is the first concern of the industry. Other responsible and ethical pharmaceutical companies would do well to follow suit."


Although the views expressed in this article do not necessarily represent the views of Ekklesia, the article may reflect Ekklesia's values. If you use Ekklesia's news briefings please consider making a donation to sponsor Ekklesia's work here.